Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • reventropy
    Junior Member
    • Apr 2014
    • 7

    Cuffcompare with a single experiment

    I am running RNA-seq analysis on a paired-end deep sequencing data set with no replicates. We are interested in finding novel gene and transcript isoforms in addition to variant info. Grooming and Tophat alignment went well and I’ve processed the .bam output through cufflinks in RABT mode with –GTF-guide. I then take the .gtf output from this and run cuffcompare with the reference .gtf and .fasta.

    I am experiencing confusion related to the last step and was hoping that somebody with more experience than I could help to clarify a few things.

    Firstly, most of the references I have read regading cuffcompare indicate that it is used for multiple replicates or experiments: “Used to Track Cufflinks transcripts across multiple experiments (e.g. across a time course)”. Is it common to use cuffcompare on a single experiment in order to find novel isoforms?

    Secondly, there are some entries in the output from cuffcompare that aren’t making sense to me. What does it mean when I see an "=" class code with a zero FMI? How about a "j" class code with a FMI of 100? Based on the definition of FMI (fraction of major isoform), these scenarios don't seem possible.

    Thirdly, if I want an fpkm score for a known gene, is it common to sum all transcript fpkms belonging to that gene with an "=" class code?







    Thanks so much for any help, and let me know if I can/should provide more information!



    -Jeremy
  • mikep
    Member
    • Feb 2011
    • 45

    #2
    Originally posted by reventropy View Post
    Firstly, most of the references I have read regading cuffcompare indicate that it is used for multiple replicates or experiments: “Used to Track Cufflinks transcripts across multiple experiments (e.g. across a time course)”. Is it common to use cuffcompare on a single experiment in order to find novel isoforms?
    Depends on your definition of "common". There's no technical reason you can't (I certainly have). Usually people use the cuffcompare output as the guide file for cuffdiff. The former gives you the union set of transcripts, the latter then looks for differential expression in those transcripts.

    Secondly, there are some entries in the output from cuffcompare that aren’t making sense to me. What does it mean when I see an "=" class code with a zero FMI? How about a "j" class code with a FMI of 100? Based on the definition of FMI (fraction of major isoform), these scenarios don't seem possible.
    cuffcompare outputs all the transcripts it finds, or is told are real (exist in the guide file). "=" transcripts exist in the guide file, so are output even if there's no support for their existence. It's not clear why you think a j class transcript cannot have an FMI of 100.


    Thirdly, if I want an fpkm score for a known gene, is it common to sum all transcript fpkms belonging to that gene with an "=" class code?
    Summing fpkms is fine, but you should include novel transcripts, or rerun cufflinks without novel transcript finding.

    Comment

    • reventropy
      Junior Member
      • Apr 2014
      • 7

      #3
      Thanks a lot mikep!

      It's not clear why you think a j class transcript cannot have an FMI of 100.
      This is probably owing to my flawed reasoning.

      I was operating under the assumption that major isoforms come from the annotation file and cannot be novel. If I see an FMI of 100 and a "j" class code then should I assume that Cufflinks identified the man isoform as being novel, i.e., a novel gene?

      Thanks again for addressing my questions so that I can proceed with more confidence.

      -Jeremy

      Comment

      • mikep
        Member
        • Feb 2011
        • 45

        #4
        Originally posted by reventropy View Post
        If I see an FMI of 100 and a "j" class code then should I assume that Cufflinks identified the man isoform as being novel, i.e., a novel gene?

        -Jeremy
        Your interpretation is correct.

        Thanks again for addressing my questions so that I can proceed with more confidence.
        I would be very careful being confident in novel isoforms from cufflinks, it has a pretty high error rate. You haven't mentioned which organism you are working with but if it is human or one of the model organisms you might be better off with using just the existing annotation. If it is a few genes you care about I'd load the cufflinks output & BAM file into a genome viewer and have a look at the actual reads.

        Comment

        • reventropy
          Junior Member
          • Apr 2014
          • 7

          #5
          I would be very careful being confident in novel isoforms from cufflinks, it has a pretty high error rate. You haven't mentioned which organism you are working with but if it is human or one of the model organisms you might be better off with using just the existing annotation. If it is a few genes you care about I'd load the cufflinks output & BAM file into a genome viewer and have a look at the actual reads.
          I'll definitely keep that in the front of my mind. The sequencing is human. I have been using IGV, but am still training my eye. We're only interested in coding genes so I will be filtering the cuffdiff output, but we would like to catch any novel transcripts or gene isoforms in this subset.

          -Jeremy

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM
          • GATTACAT
            Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
            by GATTACAT
            Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
            07-01-2026, 11:43 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          30 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          34 views
          0 reactions
          Last Post SEQadmin2  
          Working...